Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-16-092315
Filing Date
2016-04-01
Accepted
2016-04-01 16:28:43
Documents
1
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v436002_sc13da.htm SC 13D/A 95728
  Complete submission text file 0001144204-16-092315.txt   97460
Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

EIN.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87670 | Film No.: 161547587
SIC: 2834 Pharmaceutical Preparations